Risultati della ricerca - Lim, Sangbin

Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib di Lim, Sun Min, Yang, San-Duk, Lim, Sangbin, Shim, Hyo Sup, Cho, Byoung Chul

Testo Testo Testo

Regulation of mitochondrial functions by protein phosphorylation and dephosphorylation di Lim, Sangbin, Smith, Kelly R., Lim, Ssang-Taek Steve, Tian, Rong, Lu, Jianrong, Tan, Ming

Testo Testo Testo

Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-Metabolism di Angajala, Anusha, Lim, Sangbin, Phillips, Joshua B., Kim, Jin-Hwan, Yates, Clayton, You, Zongbing, Tan, Ming

Testo Testo Testo

Interplay Between Immune Checkpoint Proteins and Cellular Metabolism di Lim, Sangbin, Phillips, Joshua B., da Silva, Luciana Madeira, Zhou, Ming, Fodstad, Oystein, Owen, Laurie B., Tan, Ming

Testo Testo Testo

Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylation di Jin, Yue, Cai, Qingsong, Shenoy, Anitha K., Lim, Sangbin, Zhang, Ying, Charles, Steve, Tarrash, Miriam, Fu, Xueqi, Kamarajugadda, Sushama, Trevino, Jose G., Tan, Ming, Lu, Jianrong

Testo Testo Testo

Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines di Dashdorj, Amarjargal, KR, Jyothi, Lim, Sangbin, Jo, Ara, Nguyen, Minh Nam, Ha, Joohun, Yoon, Kyung-Sik, Kim, Hyo Jong, Park, Jae-Hoon, Murphy, Michael P, Kim, Sung Soo

Testo Testo Testo

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models di Lim, Sun Min, Yang, San-Duk, Lim, Sangbin, Heo, Seong Gu, Daniel, Stetson, Markovets, Aleksandra, Minoo, Rafati, Pyo, Kyoung-Ho, Yun, Mi Ran, Hong, Min Hee, Kim, Hye Ryun, Cho, Byoung Chul

Testo Testo Testo

Immunoregulatory protein B7-H3 reprograms glucose metabolism in cancer cells by ROS-mediated stabilization of HIF-1α di Lim, Sangbin, Liu, Hao, da Silva, Luciana Madeira, Arora, Ritu, Liu, Zixing, Phillips, Joshua B., Schmitt, David C., Vu, Tung, McClellan, Steven, Lin, Yifeng, Lin, Wensheng, Piazza, Gary A., Fodstad, Oystein, Tan, Ming

Testo Testo Testo

SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models di Synn, Chun‐Bong, Kim, Sung Eun, Lee, Hee Kyu, Kim, Min‐Hwan, Kim, Jae Hwan, Lee, Ji Min, Jo, Ha Ni, Lee, Wongeun, Kim, Dong Kwon, Byeon, Youngseon, Kim, Young Seob, Yun, Mi Ran, Park, Chae‐Won, Yun, Jiyeon, Lim, Sangbin, Heo, Seong Gu, Yang, San‐Duk, Lee, Eun Ji, Lee, Seul, Choi, Hunmi, Lee, You Won, Cho, Jae Seok, Kim, Do Hee, Park, Sungho, Kim, Jung‐Ho, Choi, Yewon, Lee, Sung Sook, Ahn, Beung‐Chul, Kim, Chang Gon, Lim, Sun Min, Hong, Min Hee, Kim, Hye Ryun, Pyo, Kyoung‐Ho, Cho, Byoung Chul

Testo Testo Testo